Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2026-01-18 @ 12:54 PM
Study NCT ID:
NCT00295750
Status:
COMPLETED
Last Update Posted:
2012-12-19
First Post:
2006-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
Sponsor:
Ferring Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FE200486 CS21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None